Presbyopia Pipeline Therapeutics Development Market Report in H1 2017

30 pages report new report on Presbyopia – Pipeline Review, H1 2017 is provide an overview of the Presbyopia (Ophthalmology) pipeline landscape. Presbyopia (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Pharmaceutical and Healthcare latest pipeline guide Presbyopia Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Presbyopia (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Presbyopia is an eye condition in which eye slowly loses the ability to focus quickly on objects that are close. Presbyopia happens in people as they age. Signs and symptoms include headaches, eyestrain, difficulty reading small print and fatigue. Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis and eye trauma.

Discount on this report http://www.reportsnreports.com/contacts/discount.aspx?name=1117843

The Presbyopia (Ophthalmology) pipeline guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Companies are Acucela Inc, Allergan Plc, Johnson & Johnson, Novartis AG

Presbyopia – Drug Profiles – oxymetazoline hydrochloride + pilocarpine hydrochloride, EV-06, lanosterol, oxymetazoline hydrochloride, PresbiDrops, Small Molecules to Inhibit Beta-L Crystallin for Cataract and Presbyopia, VP-1001

Order a copy of this research report at http://www.reportsnreports.com/purchase.aspx?name=1117843

The Recurrent Malignant Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Recurrent Malignant Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 3, 2, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Presbyopia (Ophthalmology).
• The pipeline guide reviews pipeline therapeutics for Presbyopia (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Presbyopia (Ophthalmology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Presbyopia (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Presbyopia (Ophthalmology)

Get more details on this report http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1117843

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at [email protected] This e-mail address is being protected from spambots. ReportsnReports.com offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.